Market Cap 6.74B
Revenue (ttm) 294.01M
Net Income (ttm) 27.73M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 9.43%
Debt to Equity Ratio 0.00
Volume 356,000
Avg Vol N/A
Day's Range N/A - N/A
Shares Out 254.40M
Stochastic %K 58%
Beta N/A
Analysts Hold
Price Target $56.00

Company Profile

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharm...

Industry: Biotechnology
Sector: Healthcare
Phone: 866 771 8946
Fax: 866 479 4925
Address:
750 West John Carpenter Freeway, Suite 800, Irving, United States
GoVeryLong
GoVeryLong Jul. 9 at 5:45 PM
0 · Reply
GoVeryLong
GoVeryLong Jul. 8 at 6:32 PM
0 · Reply
Wake44
Wake44 Jul. 8 at 3:45 PM
$CAI Nothing but a hedge fund playing games everyday..
0 · Reply
BigSqueezeComing
BigSqueezeComing Jul. 8 at 10:44 AM
$CAI Caris Life Sciences Announces New Study Demonstrating the Power and Clinical Utility of its Caris Assure Blood-Based Assay for Multi-Cancer Early Detection, Minimal Residual Disease and Therapy Selection By PR Newswire | July 08, 2025, 6:30 AM
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine Jul. 8 at 10:34 AM
$CAI drops bombshell validation study for Caris Assure® - 95.7% sensitivity in cancer detection at 99.6% specificity. The AI-powered liquid biopsy now eyes early detection & monitoring markets. While the tech screams 'game-changer', that 16.3x P/S ratio leaves zero margin for commercialization stumbles. Tissue biopsy's worst nightmare just got real. https://www.prnewswire.com/news-releases/caris-life-sciences-announces-new-study-demonstrating-the-power-and-clinical-utility-of-its-caris-assure-blood-based-assay-for-multi-cancer-early-detection-minimal-residual-disease-and-therapy-selection-302499499.html
0 · Reply
Wake44
Wake44 Jul. 7 at 1:54 PM
$CAI They are sure trying to discourage people here...
1 · Reply
Wake44
Wake44 Jul. 3 at 1:58 PM
$CAI Seriously not one green day for a week .. Ridiculous...
1 · Reply
GoVeryLong
GoVeryLong Jul. 2 at 4:18 PM
$CAI is a sleeper. Once people realize how much this company is growing with their technology investors will warm up to it. $UNH
1 · Reply
Wake44
Wake44 Jul. 2 at 1:51 PM
$CAI Total manipulation everyday!!
0 · Reply
GoVeryLong
GoVeryLong Jul. 2 at 9:11 AM
0 · Reply
GoVeryLong
GoVeryLong Jul. 9 at 5:45 PM
0 · Reply
GoVeryLong
GoVeryLong Jul. 8 at 6:32 PM
0 · Reply
Wake44
Wake44 Jul. 8 at 3:45 PM
$CAI Nothing but a hedge fund playing games everyday..
0 · Reply
BigSqueezeComing
BigSqueezeComing Jul. 8 at 10:44 AM
$CAI Caris Life Sciences Announces New Study Demonstrating the Power and Clinical Utility of its Caris Assure Blood-Based Assay for Multi-Cancer Early Detection, Minimal Residual Disease and Therapy Selection By PR Newswire | July 08, 2025, 6:30 AM
0 · Reply
Rage_Against_The_Machine
Rage_Against_The_Machine Jul. 8 at 10:34 AM
$CAI drops bombshell validation study for Caris Assure® - 95.7% sensitivity in cancer detection at 99.6% specificity. The AI-powered liquid biopsy now eyes early detection & monitoring markets. While the tech screams 'game-changer', that 16.3x P/S ratio leaves zero margin for commercialization stumbles. Tissue biopsy's worst nightmare just got real. https://www.prnewswire.com/news-releases/caris-life-sciences-announces-new-study-demonstrating-the-power-and-clinical-utility-of-its-caris-assure-blood-based-assay-for-multi-cancer-early-detection-minimal-residual-disease-and-therapy-selection-302499499.html
0 · Reply
Wake44
Wake44 Jul. 7 at 1:54 PM
$CAI They are sure trying to discourage people here...
1 · Reply
Wake44
Wake44 Jul. 3 at 1:58 PM
$CAI Seriously not one green day for a week .. Ridiculous...
1 · Reply
GoVeryLong
GoVeryLong Jul. 2 at 4:18 PM
$CAI is a sleeper. Once people realize how much this company is growing with their technology investors will warm up to it. $UNH
1 · Reply
Wake44
Wake44 Jul. 2 at 1:51 PM
$CAI Total manipulation everyday!!
0 · Reply
GoVeryLong
GoVeryLong Jul. 2 at 9:11 AM
0 · Reply
Wake44
Wake44 Jul. 1 at 6:24 PM
$CAI Fuckin joke...Looks like complete manipulation!!
0 · Reply
GambleLifeAway
GambleLifeAway Jul. 1 at 1:06 PM
$CAI of course the price isn’t going to move or attract more investors - there hasn’t been any news since launch! Announce something or retract the IPO if you want attraction to the company. R&D has always been sluggish for Caris. It has been a failure of an IPO thus far, which is sad considering the tech and capability far surpasses $TEM, $GH and $FMI.
0 · Reply
GoVeryLong
GoVeryLong Jul. 1 at 10:38 AM
$CAI good to see. MI finally hit the market for purchase.
0 · Reply
Wake44
Wake44 Jun. 30 at 4:17 PM
$CAI Dont understand the selling here at these levels...
1 · Reply
shameonyou
shameonyou Jun. 28 at 11:50 AM
$CAI not even the employees are on the board? Watchers haven’t moved at all
0 · Reply
GoVeryLong
GoVeryLong Jun. 27 at 11:53 AM
0 · Reply
GoVeryLong
GoVeryLong Jun. 26 at 7:11 PM
$NVDA $CAI keep your eye on them next for a breakout.
0 · Reply
GoVeryLong
GoVeryLong Jun. 26 at 7:09 PM
$CYN $CAI CAI is another AI stock to keep your eye on.
0 · Reply
TheMeatCutter
TheMeatCutter Jun. 25 at 6:49 PM
$CAI … kinda quiet in here ?!? Anybody home??
0 · Reply
Wake44
Wake44 Jun. 25 at 2:21 PM
$CAI Should be going up not down!
0 · Reply
shameonyou
shameonyou Jun. 25 at 12:38 PM
$CAI nobody here
0 · Reply
rulzart
rulzart Jun. 24 at 2:33 PM
$SLDE $CAI some interesting IPO's this month. Both are experiencing decreased volume though
0 · Reply